🇺🇸 FDA
Patent

US 7537765

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

granted A61KA61K31/215A61K31/56

Quick answer

US patent 7537765 (Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K31/215, A61K31/56, A61K31/567, A61K45/06